These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15912620)

  • 41. HIV/AIDS: Latin America & Caribbean. HAITI: making headway under hellacious circumstances.
    Cohen J
    Science; 2006 Jul; 313(5786):470-3. PubMed ID: 16873641
    [No Abstract]   [Full Text] [Related]  

  • 42. US disburses first round of AIDS funds.
    Surendran A
    Nat Med; 2004 Apr; 10(4):323. PubMed ID: 15156586
    [No Abstract]   [Full Text] [Related]  

  • 43. The new Medicare drug plan: implications for people living with HIV/AIDS.
    HRSA Careaction; 2005 Oct; ():1-8. PubMed ID: 16479678
    [No Abstract]   [Full Text] [Related]  

  • 44. [Drugs for antiretroviral therapy. The costs of HAART].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
    [No Abstract]   [Full Text] [Related]  

  • 45. [To finish theoretically with AIDS].
    Nau JY
    Rev Med Suisse; 2008 Dec; 4(183):2705. PubMed ID: 19157288
    [No Abstract]   [Full Text] [Related]  

  • 46. Hot topics for FAQs.
    HIV Prev Plus; 2004; 5(4):2. PubMed ID: 16456956
    [No Abstract]   [Full Text] [Related]  

  • 47. CalPERS to reopen drug giant's AIDS drug-pricing issue.
    AIDS Policy Law; 2003 Dec; 18(22):9. PubMed ID: 14974405
    [No Abstract]   [Full Text] [Related]  

  • 48. HIV treatment costs balloon for clinics as funding remains flat. ART costs are the highest, research shows.
    AIDS Alert; 2009 Apr; 24(4):37-9. PubMed ID: 19382361
    [No Abstract]   [Full Text] [Related]  

  • 49. Women and HIV.
    Laurence J
    AIDS Read; 2007 Dec; 17(12):574, 580. PubMed ID: 18178972
    [No Abstract]   [Full Text] [Related]  

  • 50. The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda.
    Marseille E; Saba J; Muyingo S; Kahn JG
    AIDS; 2006 Apr; 20(6):907-14. PubMed ID: 16549976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
    Di Giambenedetto S; Zazzi M; Corsi P; Gonnelli A; Di Pietro M; Giacometti A; Almi P; Trezzi M; Boeri E; Gianotti N; Menzo S; Del Gobbo R; Francisci D; Nerli A; Galli L; De Luca A;
    Antivir Ther; 2009; 14(3):359-69. PubMed ID: 19474470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV/AIDS: Latin America & Caribbean. Guatemala: struggling to deliver on promises and assess HIV's spread.
    Cohen J
    Science; 2006 Jul; 313(5786):480-1. PubMed ID: 16873649
    [No Abstract]   [Full Text] [Related]  

  • 53. Rethinking mandatory HIV testing.
    O'Grady B; Schüklenk U
    Bioethics; 2009 Oct; 23(8):ii. PubMed ID: 19712220
    [No Abstract]   [Full Text] [Related]  

  • 54. Management issues among children living with HIV looking ahead.
    Shet A; Kumarasamy N
    Indian Pediatr; 2008 Dec; 45(12):955-60. PubMed ID: 19129561
    [No Abstract]   [Full Text] [Related]  

  • 55. The impact of microbicides and changes in condom usage on HIV prevalence in men and women.
    Chen FH
    AIDS; 2006 Jul; 20(11):1551-3. PubMed ID: 16847411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Perinatally acquired HIV-1 infection: prevention and evaluation of HIV-exposed infants.
    Shetty AK
    Semin Pediatr Infect Dis; 2005 Oct; 16(4):282-95. PubMed ID: 16210108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment.
    Platt L; Bobrova N; Rhodes T; Uusküla A; Parry JV; Rüütel K; Talu A; Abel K; Rajaleid K; Judd A
    AIDS; 2006 Oct; 20(16):2120-3. PubMed ID: 17053361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paying for life. The issues behind drug pricing.
    Huff B
    GMHC Treat Issues; 2003 Nov; 17(11):1-7. PubMed ID: 14717105
    [No Abstract]   [Full Text] [Related]  

  • 59. Overview of the HIV/AIDS epidemic, scientific research and government responses in China.
    Wang L
    AIDS; 2007 Dec; 21 Suppl 8():S3-7. PubMed ID: 18172388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sub-Saharan Africa: two reports criticize strategies. Epidemic problems show progress and problems.
    AIDS Alert; 2006 Jul; 21(7):suppl 4. PubMed ID: 16871673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.